Last reviewed · How we verify

NCT03864224

A Pilot Implementation Study of GLA:D Back

Completed Last updated 8 July 2022
What this trial tests

trial testing GLA:D Back in Low Back Pain in 190 participants. Completed in 8 June 2022.

Timeline
11 February 2019
Primary endpoint
11 February 2020
8 June 2022

Quick facts

Lead sponsorUniversity of Alberta
StatusCompleted
Study typeOBSERVATIONAL
Enrollment190
Start date11 February 2019
Primary completion11 February 2020
Estimated completion8 June 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

GLA:D Back is a program developed in Denmark to help people with persistent low back pain. This pilot study will assist in contextualizing Danish content into an English version of the program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03864224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing